Most Popular Papers*


Evaluating the Efficacy and Safety of Transitioning Patients from Natalizumab to Ocrelizumab (OCTAVE)
Kyle E Smoot, Kiren Kresa-Reahl, Pavle Repovic, Jessica Craddock, Chiayi Chen, Lindsay Lucas, Tiffany Gervasi-Follmar, and Stanley Cohan


Conference Agenda
St. Joseph Health


Understanding the Transgender Patient
Hudson Tibbetts, MSN, RN

* Based on the average number of full-text downloads per day since the paper was posted.